Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Amedisys, Inc.

Amedisys, Inc. (AMED) Stock Overview

Explore Amedisys, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AMED●NASDAQ
HealthcareMedical - Care Facilities
$100.99
$0.010(0.010%)
U.S. Market opens in 10h 15m

Amedisys, Inc. (AMED)

Meyka AI Score

Z

Key Financials

Market Cap3.3B
P/E Ratio25.76
EPS (TTM)$2.57
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$95.02

AMED Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Amedisys, Inc. (NASDAQ: AMED) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Amedisys, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AMED on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $95.02 for the NASDAQ listing.

Key metrics behind Amedisys, Inc.'s NASDAQ-traded stock include a P/E ratio of 25.76 and a market capitalization of 3.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AMED on the NASDAQ.

Price Performance (NASDAQ: AMED)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.010%
3-Month Change
3.94%
6-Month Change
9.07%
Year-to-Date (YTD) Change
11.10%
1-Year Change
4.21%
3-Year Change
-16.04%
5-Year Change
-57.39%
All-Time (Max) Change
1823.62%

Contact Information

https://www.amedisys.com
225 292 2031
3854 American Way, Baton Rouge, LA, 70816

Company Facts

190,000 Employees
IPO DateAug 17, 1994
CountryUS

Frequently Asked Questions